Current Report Filing (8-k)
February 24 2015 - 3:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): February 18, 2015
REGEN BIOPHARMA, INC.
(Exact name of small business issuer
as specified in its charter)
Nevada |
45-5192997 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Commission File No. 333-191725
4700 Spring Street, St 304, La Mesa,
California 91942
(Address of Principal Executive Offices)
(619) 702 1404
(Issuer’s telephone number)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On February 18, 2015 the Board
of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to common shareholders of record as of March 10,
2015 (“Record Date”) to be paid to common shareholders on or about March 20, 2015, such dividend to be payable in
shares of Regen’s authorized but unissued Series A Preferred Stock and to consist of one share of Series A Preferred Stock
for every ten common shares of Regen Common Stock owned as of the Record Date.
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Regen Biopharma, Inc. |
|
|
Dated: February 24, 2015 |
By: /s/ David Koos |
|
David Koos |
|
Chief Executive Officer |
Regen Biopharma (PK) (USOTC:RGBP)
Historical Stock Chart
From Apr 2024 to May 2024
Regen Biopharma (PK) (USOTC:RGBP)
Historical Stock Chart
From May 2023 to May 2024